Literature DB >> 21936010

Engineering homooligomeric proteins to detect weak intersite allosteric communication: aminotransferases, a case study.

Edgar Deu1, Jack F Kirsch.   

Abstract

The existence of low levels of intersubunit communication in homooligomeric enzymes is often difficult to discover, as the identical active sites cannot be probed individually to dissect their interdependent contributions. The homodimeric paralogs, E. coli aspartate- (AATase) and tyrosine aminotransferase (TATase), have not been demonstrated to show allostery. To address this question, we engineered a hybrid aminotransferase containing two distinct catalytic pockets: an AATase and a TATase site. The TATase/AATase hybrid was constructed by grafting an engineered TATase active site into one of the catalytic pockets of E. coli AATase. Each active site conserves its specific catalytic and inhibitor binding properties, and the hybrid catalyzes simultaneously each aminotransferase reaction at the respective site. Importantly, association of a selective inhibitor into one of the catalytic pockets decreases the activity of the second active site by up to 25%, thus proving unequivocally the existence of allosteric communication between active sites. The procedure may be applicable to other homologous sets of enzymes.
Copyright © 2011 The Protein Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21936010      PMCID: PMC3302643          DOI: 10.1002/pro.741

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  38 in total

1.  A general method for the quantitative analysis of functional chimeras: applications from site-directed mutagenesis and macromolecular association.

Authors:  T N Luong; J F Kirsch
Journal:  Protein Sci       Date:  2001-03       Impact factor: 6.725

2.  Interaction between pyridoxamine 5'-phosphate and apo-aspartate aminotransferase from pig heart. Evidence for a negative cooperativity.

Authors:  M Arrio-Dupont
Journal:  Eur J Biochem       Date:  1972-10

3.  Syncatalytic modification of a functional tyrosyl residue in aspartate aminotransferase.

Authors:  P Christen; J F Riordan
Journal:  Biochemistry       Date:  1970-07-21       Impact factor: 3.162

4.  Why is creatine kinase a dimer? Evidence for cooperativity between the two subunits.

Authors:  T Hornemann; D Rutishauser; T Wallimann
Journal:  Biochim Biophys Acta       Date:  2000-07-14

5.  The role of the conserved Lys68*:Glu265 intersubunit salt bridge in aspartate aminotransferase kinetics: multiple forced covariant amino acid substitutions in natural variants.

Authors:  Edgar Deu; Keith A Koch; Jack F Kirsch
Journal:  Protein Sci       Date:  2002-05       Impact factor: 6.725

6.  Crystal structure of glutamate-1-semialdehyde aminotransferase from Bacillus subtilis with bound pyridoxamine-5'-phosphate.

Authors:  Honghua Ge; Xinhuai Lv; Jun Fan; Yongxiang Gao; Maikun Teng; Liwen Niu
Journal:  Biochem Biophys Res Commun       Date:  2010-10-12       Impact factor: 3.575

7.  Quantitative chimeric analysis of six specificity determinants that differentiate Escherichia coli aspartate from tyrosine aminotransferase.

Authors:  Wendy A Shaffer; Tinh N Luong; Steven C Rothman; Jack F Kirsch
Journal:  Protein Sci       Date:  2002-12       Impact factor: 6.725

8.  Directed evolution relieves product inhibition and confers in vivo function to a rationally designed tyrosine aminotransferase.

Authors:  Steven C Rothman; Mark Voorhies; Jack F Kirsch
Journal:  Protein Sci       Date:  2004-02-06       Impact factor: 6.725

9.  Narrowing substrate specificity in a directly evolved enzyme: the A293D mutant of aspartate aminotransferase.

Authors:  Margaret A Chow; Kathryn E McElroy; Kevin D Corbett; James M Berger; Jack F Kirsch
Journal:  Biochemistry       Date:  2004-10-12       Impact factor: 3.162

10.  How does an enzyme evolved in vitro compare to naturally occurring homologs possessing the targeted function? Tyrosine aminotransferase from aspartate aminotransferase.

Authors:  Steven C Rothman; Jack F Kirsch
Journal:  J Mol Biol       Date:  2003-03-28       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.